(Reuters) - The number of outstanding shares rose 17 percent, diluting
the quarter's per-share earnings, which were 32 cents versus 35
cents per share a year earlier.
Mylan said that excluding amortization of 5 cents per share
and a 15-cent-per-share non-cash loss on a foreign currency
contract related to its pending acquisition of Merck KGaA's
generics business, it earned 52 cents per share.
Read more at Reuters.com Market News
the quarter's per-share earnings, which were 32 cents versus 35
cents per share a year earlier.
Mylan said that excluding amortization of 5 cents per share
and a 15-cent-per-share non-cash loss on a foreign currency
contract related to its pending acquisition of Merck KGaA's
generics business, it earned 52 cents per share.
Read more at Reuters.com Market News
No comments:
Post a Comment